Health Decisions Appoints Rich Podurgal as Chief Human Resources Officer to Support Company’s Projected Growth
“The economic downturn has made our sponsors more concerned than ever with increasing the efficiency of their clinical trials to save time and money,” said Health Decisions CEO Michael Rosenberg. “As we grow our company, Rich will play an integral part in making sure we attract and retain the best people, so we can continue to deliver results that exceed our sponsors’ expectations.”
Podurgal is responsible for managing all Human Resources and Training functions, and reports to Rosenberg. “I’m extremely impressed with the dedication and talent of everyone at Health Decisions,” said Podurgal. “I’m really looking forward to putting programs in place that will handle explosive growth while maintaining our strong culture of innovation and collaboration.”
Podurgal received a Bachelor’s degree in Business and Economics from St. Ambrose University and a Masters of Education from North Carolina State University. He brings over 25 years of human resources, training, and performance and organizational development experience to his new position, including management positions at GlaxoSmithKline and Constella Group, and most recently co-ownership of Square Peg Consulting.
For sales and marketing information, please contact Mike Watson, Director of Business Development, by email at firstname.lastname@example.org or by phone at 919 967-1111 x133.
For media information, please contact Katie Hendrick, Marketing Specialist, by email at email@example.com or by phone at 919 967-1111 x116.
About Health Decisions
Health Decisions (www.healthdec.com), a global clinical research organization (CRO), leads the industry in trial efficiency. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10 - 25% faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at www.healthdec.com.